Clinical Trials Directory

Trials / Unknown

UnknownNCT01657123

Exercise Capacity and Recovery in Addison's Disease

Effect of Hydrocortisone Stress Dose on Exercise Capacity and Post-exercise Recovery in Patients With Addison's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
UMC Utrecht · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Exposure to stress alters the activity of the adrenomedullary, adrenocortical and sympathetic nervous system, depending on the type and intensity of the stressor. Physical exercise represents a stress condition influencing many systems in the body. Given a workload of at least 70-85% of Vo2max, exercise is a potent stimulus of the hypothalamic-pituitary-adrenal (HPA)-axis. The increased endogenous cortisol secretion results in important metabolic and cardiovascular effects to maintain cellular and organ homeostasis. Patients with Addison's disease are not able to meet the increased demand of adrenal steroids in case of physical exercise, which may result in an impaired exercise capacity and a prolonged post-exercise recovery. We hypothesize that a hydrocortisone stress dose increases exercise capacity and improves post-exercise recovery in patients with Addison's disease.

Conditions

Interventions

TypeNameDescription
OTHERergometryergometry measurements
OTHERergometryErgometry measurements

Timeline

Start date
2013-01-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2012-08-03
Last updated
2012-08-03

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01657123. Inclusion in this directory is not an endorsement.